Hien Thi Tran

Array ( [id] => 6590161 [patent_doc_number] => 20020041876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'TWEAK receptor' [patent_app_type] => new [patent_app_number] => 09/742454 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16599 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20020041876.pdf [firstpage_image] =>[orig_patent_app_number] => 09742454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7118407 [patent_doc_number] => 20010001712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-05-24 [patent_title] => 'Monoclonal antibodies having property of causing apoptosis' [patent_app_type] => new-utility [patent_app_number] => 09/736146 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5819 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20010001712.pdf [firstpage_image] =>[orig_patent_app_number] => 09736146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7041272 [patent_doc_number] => 20010005747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-28 [patent_title] => 'Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity' [patent_app_type] => new-utility [patent_app_number] => 09/735173 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5731 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20010005747.pdf [firstpage_image] =>[orig_patent_app_number] => 09735173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 443311 [patent_doc_number] => 07256274 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Apoptin-associating protein' [patent_app_type] => utility [patent_app_number] => 09/733416 [patent_app_country] => US [patent_app_date] => 2000-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8904 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256274.pdf [firstpage_image] =>[orig_patent_app_number] => 09733416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500209 [patent_doc_number] => 20020025521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Pin1 as a marker for abnormal cell growth' [patent_app_type] => new [patent_app_number] => 09/726464 [patent_app_country] => US [patent_app_date] => 2000-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25741 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025521.pdf [firstpage_image] =>[orig_patent_app_number] => 09726464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963431 [patent_doc_number] => 06949243 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-27 [patent_title] => 'Methods of inhibiting metastasis' [patent_app_type] => utility [patent_app_number] => 09/721613 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10319 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949243.pdf [firstpage_image] =>[orig_patent_app_number] => 09721613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 859786 [patent_doc_number] => 07371376 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-13 [patent_title] => 'Anti-ErbB2 antibodies' [patent_app_type] => utility [patent_app_number] => 09/705579 [patent_app_country] => US [patent_app_date] => 2000-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 47 [patent_no_of_words] => 24399 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371376.pdf [firstpage_image] =>[orig_patent_app_number] => 09705579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1458564 [patent_doc_number] => 06426217 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-30 [patent_title] => 'MAGE-3 peptides presented by HLA class II molecules' [patent_app_type] => B1 [patent_app_number] => 09/697884 [patent_app_country] => US [patent_app_date] => 2000-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 26006 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/426/06426217.pdf [firstpage_image] =>[orig_patent_app_number] => 09697884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232800 [patent_doc_number] => 07598225 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-10-06 [patent_title] => 'Generation of immune response to prostate-specific antigen (PSA)' [patent_app_type] => utility [patent_app_number] => 09/693121 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10895 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598225.pdf [firstpage_image] =>[orig_patent_app_number] => 09693121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630136 [patent_doc_number] => 07132109 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-07 [patent_title] => 'Using heat shock proteins to increase immune response' [patent_app_type] => utility [patent_app_number] => 09/693643 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 17051 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132109.pdf [firstpage_image] =>[orig_patent_app_number] => 09693643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6724951 [patent_doc_number] => 20030207263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Method of screening therapeutic agents' [patent_app_type] => new [patent_app_number] => 09/601534 [patent_app_country] => US [patent_app_date] => 2000-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9710 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207263.pdf [firstpage_image] =>[orig_patent_app_number] => 09601534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1094934 [patent_doc_number] => 06821515 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-23 [patent_title] => 'Protein formulation' [patent_app_type] => B1 [patent_app_number] => 09/648896 [patent_app_country] => US [patent_app_date] => 2000-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17367 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821515.pdf [firstpage_image] =>[orig_patent_app_number] => 09648896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1331443 [patent_doc_number] => 06596503 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/641499 [patent_app_country] => US [patent_app_date] => 2000-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9937 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596503.pdf [firstpage_image] =>[orig_patent_app_number] => 09641499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 446857 [patent_doc_number] => 07253269 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-08-07 [patent_title] => 'Modified cDNA of rat bcl-x gene and modified protein' [patent_app_type] => utility [patent_app_number] => 10/049822 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 27 [patent_no_of_words] => 8467 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/253/07253269.pdf [firstpage_image] =>[orig_patent_app_number] => 10049822 [rel_patent_id] =>[rel_patent_doc_number] =>)